# Phenolic Complex k110-42 Therapy on Cognitive Functions in Down Children

> **NCT07284693** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Mansoura University** · enrollment: 108 (estimated)

## Conditions studied

- Cognitive Functions

## Interventions

- **DRUG:** Phenolic complex k110-42
- **DRUG:** Neumentix

## Key facts

- **NCT ID:** NCT07284693
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2026-07
- **Final completion:** 2026-12
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07284693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07284693, "Phenolic Complex k110-42 Therapy on Cognitive Functions in Down Children". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07284693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*